Search - tctmd.com

Displaying 1 - 20 of 98

Sort: Relevancy | Date

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

Todd Neale

December 22, 2023

News Daily News

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

L.A. McKeown

December 11, 2023

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Michael O'Riordan

December 06, 2023

News Daily News

Mortality Risk Varies Among Patients With Very High LDL Levels

Michael O'Riordan

November 17, 2023

News Conference News AHA 2023

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Yael L. Maxwell

November 17, 2023

Presentation AHA 2023

Dapagliflozin in myocardial infarction without diabetes or heart failure

Presenter: Stefan James

November 14, 2023

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Daily News

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Yael L. Maxwell

November 08, 2023

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

Presentation TCT 2023

Challenging Cases treated with DES+DCB Stent Platform

Presenter: Ricardo Costa

October 26, 2023

Presentation TCT 2023

ABILITY DIABETES GLOBAL RCT: Study Updates

Presenter: Marie-Claude Morice

October 26, 2023

Presentation TCT 2023

Tailored to treat diabetes: The gamechanger Envisolution Technology

Presenter: Alexandre Abizaid

October 26, 2023

Presentation TCT 2023

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Presenter: Roxana Mehran

October 26, 2023

Optimal Revascularization Strategies in Patient with DM: Case Presentation

Presentation TCT 2023

Complex PCI in patients with DM: Cases Presentation

Presenter: Luca Testa

October 26, 2023

Presentation TCT 2023

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

Presenter: Giulio Stefanini

October 26, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Advertisement

AHA Selects 2023’s Leading Cardiovascular Research

Rethink Race in Pooled Cohort Equations for ASCVD, REGARDS Data Suggest

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

No Safety Concerns Seen With Inclisiran in Large ORION Analysis

Mortality Risk Varies Among Patients With Very High LDL Levels

‘Proof-of-Concept’ AI-ECG May Improve STEMI Care: ARISE

Dapagliflozin in myocardial infarction without diabetes or heart failure

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Guiding DAPT Based on Genes or Platelet Tests Still ‘Tempting’

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

Challenging Cases treated with DES+DCB Stent Platform

ABILITY DIABETES GLOBAL RCT: Study Updates

Tailored to treat diabetes: The gamechanger Envisolution Technology

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Complex PCI in patients with DM: Cases Presentation

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content